SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Official Melania Meme (MELANIA) is a cryptocurrency and operates on the Solana platform. Official Melania Meme has a current supply of 999,995,392.634966 with 999,995,392.634962 in circulation. The last known price of Official Melania Meme is 0.04540986 USD and is down -12.94 over the last 24 hours. It is currently trading on 310 active market(s) with $4,518,778.32 traded over the last 24 hours. More information can be found at https://melaniameme.com/.

Melania Trump

MELANIA is drawing attention amid continued losses from its launch highs, with many traders calling the Trump-linked meme coin a scam or a token with little utility and questioning whether it can recover. A smaller group is treating the low price as a buying opportunity, but bearish sentiment dominates.

Shiba Inu (SHIB) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Shiba Inu has a current supply of 589,495,699,860,951.91490568 with 589,238,106,731,035.4551592 in circulation. The last known price of Shiba Inu is 0.00000379 USD and is down -10.85 over the last 24 hours. It is currently trading on 1128 active market(s) with $78,538,817.41 traded over the last 24 hours. More information can be found at https://shibatoken.com/.

Shiba Inu

SHIB is drawing attention for weak, choppy price action, with traders sharing bearish technical reads and frustration about its prolonged stagnation. Some are buying dips and anticipating a meme-coin rebound alongside broader crypto strength, while others expect further declines; no specific catalyst is established.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention ahead of the FDAs decision on ivonescimab for EGFR-mutated lung cancer, with traders watching for an approval, rejection, or delay. The debate centers on strong progression-free-survival results versus the FDAs stated need for statistically significant overall-survival evidence, which the original analysis narrowly missed; no decision is confirmed in the discussion.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos Q3 update and reactor-development milestones, including progress securing manufacturing capacity, have fueled a volatile rebound in the shares. Bulls point to its cash balance and AI-related power demand, while skeptics cite the pre-revenue business, long commercialization timeline, valuation, and insider selling or dilution concerns.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASMLs quarterly results and outlook have fueled debate: traders point to strong AI-driven demand and equipment supply constraints, but the shares fell despite the positive business commentary. Bulls view the pullback as an opportunity given ASMLs lithography moat, while bears question valuation and whether semiconductor customers capital spending can sustain the order outlook.

Litecoin (LTC) is a cryptocurrency . Users are able to generate LTC through the process of mining. Litecoin has a current supply of 84,000,000 with 77,830,936.34364598 in circulation. The last known price of Litecoin is 43.58319249 USD and is down -11.87 over the last 24 hours. It is currently trading on 1567 active market(s) with $330,181,316.06 traded over the last 24 hours. More information can be found at https://litecoin.org/.

Litecoin

Litecoin is under pressure alongside a broader crypto selloff, with traders complaining that LTC has fallen harder than other coins and repeatedly erased prior gains. The conversation is split between bearish calls for more downside and holders buying the dip or watching for support and a rebound.

Bonk (BONK) is a cryptocurrency launched in 2022and operates on the Solana platform. Bonk has a current supply of 87,994,294,506,933.453125. The last known price of Bonk is 0.00000228 USD and is down -15.54 over the last 24 hours. It is currently trading on 848 active market(s) with $48,911,926.49 traded over the last 24 hours. More information can be found at https://www.bonkcoin.com/.

BONK

BONKs sharp pullback has traders debating whether the meme coin is in a continuing decline or near a bottom: some call it a bull trap and say they are cutting losses, while others are buying the dip and expecting a rebound. Speculation about a BonkFun relaunch and continued holder growth adds to bullish hopes, but no confirmed catalyst dominates the discussion.

Select Sector SPDR Trust (The) - State Street Utilities Select Sector SPDR ETF

Utilities Select Sector SPDR Fund

XLU is drawing attention for a technical rebound and reported inverse-head-and-shoulders breakout, alongside discussion of rotation into defensive, rate-sensitive utilities amid market uncertainty. Traders are split between bullishness on the setup and caution that Treasury-yield moves can pressure utilities and that the safety trade may be fading.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

RASONQUEs commercial launch for metastatic pancreatic cancer is drawing attention, with strong early uptake countered by concern that sales may slow and spending will remain high. Traders are debating the disconnect between the drugs promising debut and RVMDs recent share weakness, while also watching European approval and pipeline progress.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

Traders are focused on a potential VIX surge and broader market pullback, citing concerns about rates, oil, tech weakness and geopolitical risks while positioning in UVIX as a volatility hedge. Others warn that the leveraged ETF can lose value through decay and may fade if volatility does not rise, leaving debate over whether the anticipated spike is near.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
